In June 2026, researchers from UC Davis, Brown University and Mass General Brigham published in Nature Medicine the longest real-world experience to date with a speech brain-computer interface (BCI). Casey Harrell, a man with amyotrophic lateral sclerosis (ALS) and severe paralysis and speech impairment, used the implanted system independently at home, on a near-daily basis, for almost two years.

The device, part of the BrainGate2 clinical trial, consists of four microelectrode arrays with 256 electrodes implanted in the speech motor cortex. Algorithms decode his attempted speech into text and his attempted hand movements into cursor control. During the study he used the system for more than 3,800 hours and communicated 183,060 sentences, close to 2 million words, at an average of 56 words per minute. In structured testing, word accuracy exceeded 99% with a vocabulary of more than 125,000 words.

Model of a head with an implanted brain-computer interface pedestal
Model of a head with an implanted brain-computer interface pedestal. Image: public domain, via Wikimedia Commons.

What makes this study a milestone is independence: unlike earlier BCIs that required a research team to be present, he could use the system whenever he wanted, sometimes for more than 12 hours straight, to send emails, browse the internet and continue working full time. Experts described it as a sign that BCIs are beginning to become medical devices rather than research tools.

Other 2026 studies point in the same direction. In March, BrainGate researchers reported in Nature Neuroscience a typing neuroprosthesis that allowed a participant to type at 22 words per minute with a 1.6% word error rate, after calibration with as few as 30 sentences. Several companies have also advanced implant trials in people with paralysis.

Limitations remain: the Nature Medicine study involved a single participant, the device still requires surgery and some caregiver training, and no implanted BCI has yet received full marketing approval in the United States.

Source: Card NS et al. Nature Medicine, 2026

↑